NEWS

NEWS
Participated in “Startup Horizon 2024 -Countdown to Global Startup EXPO Event 2025-” as a speaker

Speaker at Startup Horizon 2024 -Countdown to Global Startup EXPO Event 2025-, organised by the Ministry of Economy, Trade and Industry, METI Kinki and JETRO (Japan External Trade Organisation).https://global-startup-expo.go.jp/startup-horizon2024/

Read more
NEWS
The start date for the investigator-initiated clinical trial of a tooth regeneration treatment for congenital edentulism ( known as “teething medicine”) has been set.

Tazuke Kofukai FoundationThe research plan (approved by the Pharmaceuticals and Medical Devices Agency (PMDA) on 25 March 2024) for a tooth regeneration treatment for congenital edentulism ( known as “teething medicine”) being conducted by the Kitano Hospital and affiliated groups. The start date of the investigator-initiated clinical trial at Kyoto University Hospital has now been […]

Read more
NEWS
Exhibited a booth at BioJapan 2024 held on October 9-11, 2024

We exhibited at a booth at BioJapan2024, which took place from 9-11 October 2024. We are pleased to announce that we exhibited at BioJapan2024, one of Asia's largest partnering events in the life science field (booth number: D-82). The event was held from 9-11 October at Pacifico Yokohama. Kiso and Takahashi also spoke at seminars. […]

Read more
NEWS
We were on the stage at "Thursday Gathering #305 KANSAI Startup Night Vol.7

19 Sep 2024|Thursday Gathering #305 KANSAI Startup Night Vol 7. For more information, please visit the following URL.https://thursdaygathering-20240919.peatix.com/

Read more
NEWS
Tohoku University Venture Partners, JIC Venture Growth Investments, Astellas Venture Management LLC, and eight other companies, as well as an AMED grant, raised a total of approximately 1.5 billion yen in Series B round funding.

Toregem has raised a total of approximately JPY 1.5 billion in funding through a third-party allotment of new shares (Series B) and a grant from the 2024 “Drug Discovery Venture Ecosystem Enhancement Project (Drug Discovery Venture Open Call)” (4th round) of the National Institute for Medical Research and Development (AMED). With this funding, the company […]

Read more